Telemedical assistance for oxygen management in intensive care patients
Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients
This study is testing a new telemedicine system that helps manage oxygen levels for patients in intensive care with lung problems to see if it can make better treatment suggestions than doctors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Pauls Stradins Clinical University Hospital Academic / other |
| Locations | 1 site (Riga) |
| Trial ID | NCT06090149 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to validate a telemedical system designed for monitoring respiratory function and proposing automated oxygen treatment for intensive care patients suffering from acute or chronic lung diseases. Participants will have their clinical parameters continuously recorded, and samples will be analyzed to assess their respiratory status. The study will compare clinician decisions on ventilation adjustments with the system's automated proposals to evaluate its readiness for further development into a fully automated closed-loop ventilation system.
Who should consider this trial
Good fit: Ideal candidates include hospitalized adults over 18 years with acute respiratory failure requiring non-invasive ventilation due to restrictive or obstructive lung disease.
Not a fit: Patients who may not benefit include those under 18 years, pregnant individuals, or those contraindicated for non-invasive ventilation.
Why it matters
Potential benefit: If successful, this approach could enhance the management of oxygen therapy in critically ill patients, potentially improving their outcomes.
How similar studies have performed: Other studies have shown promise in using telemedicine and automated systems for respiratory management, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * signed informed consent to participate in the study; * aged over 18 years; * patients hospitalized with acute respiratory failure (indication to NIV therapy) with restrictive or obstructive lung disease Exclusion Criteria: * refusal to participate further in the study; * age under 18 years; * pregnancy; * the patient is contraindicated for non-invasive lung ventilation * during the study, the patients condition worsens in such a way that an active one is required medical intervention or continuation of the study may worsen the patients condition; * complications related to NIV therapy or claustrophobia; * chronic obstructive pulmonary disease and obstructive sleep apnea without documented hypoxemia (Sp02 and Sa02 \> 94%).
Where this trial is running
Riga
- Pauls Stradins Clinical Univeristy Hospital — Riga, Latvia (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.